Texas clocks in as 5th hardest-working state in U.S., survey says

LAUDING TEXAS’ LABOR FORCE

We work hard for the money in Houston. Photo by Hinterhaus Productions/Getty

n the 1980s, disco queen Donna Summer sang the praises of a blue-collar woman in the hit tune “She Works Hard for the Money.” If the song were to be updated for this decade, it might morph into an ode to the hardworking women and men of Texas.

A new ranking from personal finance website WalletHub puts Texas at No. 5 among the hardest-working states. The Lone Star State repeated its fifth-place showing from last year. In the 2022 study, Texas is preceded by North Dakota, Alaska, Nebraska, and South Dakota. The slackers, it appears, are in bottom-ranked New Mexico.

WalletHub evaluated each state based on 10 metrics. In the Labor Day-timed study, Texas earned an especially high mark for the average number of hours worked per week (ranked fourth).In July 2022, nearly 14.6 million people were part of the state’s civilian workforce (which excludes active-duty military personnel), according to the U.S. Bureau of Labor Statistics. That month, the state’s unemployment rate stood at 4 percent.

In a news release touting the July 2022 job numbers for Texas, Gov. Greg Abbott highlighted the state’s “young, skilled, diverse, and growing workforce.”

“Texas jobs are booming, and more Texans are working than ever before as we again break all previous records for total jobs,” Abbott says. “Despite the economic challenges job creators are facing across the nation, businesses are investing with confidence in the Lone Star State because we’ve built a framework that allows free enterprise to flourish and hardworking Texans to succeed.”

------

this article originally ran on CultureMap.

Workers in the Lone Star State put in more hours and take less vacation time than most of America. Photo by gguy44/Getty Images

New report proves Texans work harder than almost anyone else in U.S.

SERIOUSLY, TAKE A BREAK

Texans don't just work hard, they work harder than almost anyone else in the nation, according to a new study.

Just in time for Labor Day, WalletHub has revealed the hardest-working states for 2019, and Texas lands at No. 4, meaning only three states — North Dakota, Alaska, and South Dakota — work harder. To determine the ranking, the personal finance site reviewed a host of factors, from average workweek, commute time, and leisure time to employment rates and the share of workers with multiple jobs.

In Texas, where 96 percent of the labor force has a job, workers stay on the clock an average of 40 hours a week. While that might seem pretty standard, somehow, that makes us the state with the fourth-longest workweek.

And those hardworking Texans could use a break. Surprisingly, 29 percent of the state's workers don't use all of their vacation time. One contributing factor could be the state's high percentage of engaged workers (35 percent), described in the study as "involved in, enthusiastic about, and committed to their work and workplace."

As we know, work doesn't just start and end at your desk. WalletHub also measured workers' commute times, volunteer hours, and leisure time, which it categorized as indirect work factors.

In Texas, workers regularly travel about 26 minutes one way for their jobs, and despite their long workweeks, they make time to volunteer for 27 hours each year on average. In regards to work-life balance, Texans set aside almost six hours a day for leisure time. That may sound ample, but workers in 19 other states spend even more time relaxing.

This isn't the only recent study to call attention to how much time Texans spend on the clock.

A recent report from mobile technology company Kisi named Houston, where workers clock 43.7 hours a week, the second most overworked city in the U.S., second only to Washington, D.C. Austin also shot to the top of the list, with workers laboring 43.5 hours a week, followed by San Antonio (43.1 hours) and Dallas (42.9 hours).

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

5 Houston scientists named winners of prestigious Hill Prizes 2026

prized research

Five Houston scientists were recognized for their "high-risk, high-reward ideas and innovations" by Lyda Hill Philanthropies and the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

The 2026 Hill Prizes provide seed funding to top Texas researchers. This year's prizes were given out in seven categories, including biological sciences, engineering, medicine, physical sciences, public health and technology, and the new artificial intelligence award.

Each recipient’s institution or organization will receive $500,000 in direct funding from Dallas-based Lyda Hill Philanthropies. The organization has also committed to giving at least $1 million in discretionary research funding on an ad hoc basis for highly-ranked applicants who were not selected as recipients.

“It is with great pride that I congratulate this year’s Hill Prizes recipients. Their pioneering spirit and unwavering dedication to innovation are addressing some of the most pressing challenges of our time – from climate resilience and energy sustainability to medical breakthroughs and the future of artificial intelligence,” Lyda Hill, founder of Lyda Hill Philanthropies, said in a news release.

The 2026 Houston-area recipients include:

Biological Sciences: Susan M. Rosenberg, Baylor College of Medicine

Rosenberg and her team are developing ways to fight antibiotic resistance. The team will use the funding to screen a 14,000-compound drug library to identify additional candidates, study their mechanisms and test their ability to boost antibiotic effectiveness in animal models. The goal is to move toward clinical trials, beginning with veterans suffering from recurrent infections.

Medicine: Dr. Raghu Kalluri, The University of Texas MD Anderson Cancer Center

Kalluri is developing eye drops to treat age-related macular degeneration (AMD), the leading cause of vision loss globally. Kalluri will use the funding to accelerate studies and support testing for additional ocular conditions. He was also named to the National Academy of Inventors’ newest class of fellows last month.

Engineering: Naomi J. Halas, Rice University

Co-recipeints: Peter J. A. Nordlander and Hossein Robatjazi, Rice University

Halas and her team are working to advance light-driven technologies for sustainable ammonia synthesis. The team says it will use the funding to improve light-driven catalysts for converting nitrogen into ammonia, refine prototype reactors for practical deployment and partner with industry collaborators to advance larger-scale applications. Halas and Nordlander are co-founders of Syzygy Plasmonics, and Robatjazi serves as vice president of research for the company.

The other Texas-based recipients include:

  • Artificial Intelligence: Kristen Grauman, The University of Texas at Austin
  • Physical Sciences: Karen L. Wooley, Texas A&M University; Co-Recipient: Matthew Stone, Teysha Technologies
  • Public Health: Dr. Elizabeth C. Matsui, The University of Texas at Austin and Baylor College of Medicine
  • Technology: Kurt W. Swogger, Molecular Rebar Design LLC; Co-recipients: Clive Bosnyak, Molecular Rebar Design, and August Krupp, MR Rubber Business and Molecular Rebar Design LLC

Recipients will be recognized Feb. 2 during the TAMEST 2026 Annual Conference in San Antonio. They were determined by a committee of TAMEST members and endorsed by a committee of Texas Nobel and Breakthrough Prize Laureates and approved by the TAMEST Board of Directors.

“On behalf of TAMEST, we are honored to celebrate the 2026 Hill Prizes recipients. These outstanding innovators exemplify the excellence and ambition of Texas science and research,” Ganesh Thakur, TAMEST president and a distinguished professor at the University of Houston, added in the release. “Thanks to the visionary support of Lyda Hill Philanthropies, the Hill Prizes not only recognize transformative work but provide the resources to move bold ideas from the lab to life-changing solutions. We are proud to support their journeys and spotlight Texas as a global hub for scientific leadership.”

Investment bank opens new Houston office focused on energy sector

Investment bank Cohen & Co. Capital Markets has opened a Houston office to serve as the hub of its energy advisory business and has tapped investment banking veteran Rahul Jasuja as the office’s leader.

Jasuja joined Cohen & Co. Capital Markets, a subsidiary of financial services company Cohen & Co., as managing director, and head of energy and energy transition investment banking. Cohen’s capital markets arm closed $44 billion worth of deals last year.

Jasuja previously worked at energy-focused Houston investment bank Mast Capital Advisors, where he was managing director of investment banking. Before Mast Capital, Jasuja was director of energy investment banking in the Houston office of Wells Fargo Securities.

“Meeting rising [energy] demand will require disciplined capital allocation across traditional energy, sustainable fuels, and firm, dispatchable solutions such as nuclear and geothermal,” Jasuja said in a news release. “Houston remains the center of gravity where capital, operating expertise, and execution come together to make that transition investable.”

The Houston office will focus on four energy verticals:

  • Energy systems such as nuclear and geothermal
  • Energy supply chains
  • Energy-transition fuel and technology
  • Traditional energy
“We are making a committed investment in Houston because we believe the infrastructure powering AI, defense, and energy transition — from nuclear to rare-earth technology — represents the next secular cycle of value creation,” Jerry Serowik, head of Cohen & Co. Capital Markets, added in the release.

---

This article originally appeared on EnergyCaptialHTX.com.

MD Anderson makes AI partnership to advance precision oncology

AI Oncology

Few experts will disagree that data-driven medicine is one of the most certain ways forward for our health. However, actually adopting it comes at a steep curve. But what if using the technology were democratized?

This is the question that SOPHiA GENETICS has been seeking to answer since 2011 with its universal AI platform, SOPHiA DDM. The cloud-native system analyzes and interprets complex health care data across technologies and institutions, allowing hospitals and clinicians to gain clinically actionable insights faster and at scale.

The University of Texas MD Anderson Cancer Center has just announced its official collaboration with SOPHiA GENETICS to accelerate breakthroughs in precision oncology. Together, they are developing a novel sequencing oncology test, as well as creating several programs targeted at the research and development of additional technology.

That technology will allow the hospital to develop new ways to chart the growth and changes of tumors in real time, pick the best clinical trials and medications for patients and make genomic testing more reliable. Shashikant Kulkarni, deputy division head for Molecular Pathology, and Dr. J. Bryan, assistant professor, will lead the collaboration on MD Anderson’s end.

“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” Dr. Donna Hansel, division head of Pathology and Laboratory Medicine at MD Anderson, said in a press release. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”

SOPHiA GENETICS is based in Switzerland and France, and has its U.S. offices in Boston.

“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” Dr. Philippe Menu, chief product officer and chief medical officer at SOPHiA GENETICS, added in the release. “With SOPHiA DDM as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”

View All Listings